CareDx Inc
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution … Read more
CareDx Inc (CDNA) - Total Assets
Latest total assets as of September 2025: $432.31 Million USD
Based on the latest financial reports, CareDx Inc (CDNA) holds total assets worth $432.31 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CareDx Inc - Total Assets Trend (2012–2024)
This chart illustrates how CareDx Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CareDx Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
CareDx Inc's total assets of $432.31 Million consist of 71.7% current assets and 28.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 23.4% |
| Accounts Receivable | $64.61 Million | 13.2% |
| Inventory | $19.50 Million | 4.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $38.18 Million | 7.8% |
| Goodwill | $40.34 Million | 8.2% |
Asset Composition Trend (2012–2024)
This chart illustrates how CareDx Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CareDx Inc's current assets represent 71.7% of total assets in 2024, a decrease from 77.0% in 2012.
- Cash Position: Cash and equivalents constituted 23.4% of total assets in 2024, down from 59.0% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 13.2% of total assets.
CareDx Inc Competitors by Total Assets
Key competitors of CareDx Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
CareDx Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - CareDx Inc generates 0.68x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, CareDx Inc generates $ 10.70 in net profit.
CareDx Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.03 | 4.10 | 3.95 |
| Quick Ratio | 2.75 | 3.87 | 3.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $201.24 Million | $ 252.65 Million | $ 203.88 Million |
CareDx Inc - Advanced Valuation Insights
This section examines the relationship between CareDx Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.24 |
| Latest Market Cap to Assets Ratio | 1.79 |
| Asset Growth Rate (YoY) | 5.2% |
| Total Assets | $491.05 Million |
| Market Capitalization | $878.73 Million USD |
Valuation Analysis
Above Book Valuation: The market values CareDx Inc's assets above their book value (1.79 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: CareDx Inc's assets grew by 5.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CareDx Inc (2012–2024)
The table below shows the annual total assets of CareDx Inc from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $491.05 Million | +5.19% |
| 2023-12-31 | $466.83 Million | -14.03% |
| 2022-12-31 | $542.99 Million | -4.17% |
| 2021-12-31 | $566.62 Million | +53.76% |
| 2020-12-31 | $368.51 Million | +142.86% |
| 2019-12-31 | $151.74 Million | +16.10% |
| 2018-12-31 | $130.70 Million | +56.40% |
| 2017-12-31 | $83.56 Million | +8.91% |
| 2016-12-31 | $76.73 Million | +37.91% |
| 2015-12-31 | $55.64 Million | -9.00% |
| 2014-12-31 | $61.14 Million | +519.27% |
| 2013-12-31 | $9.87 Million | -0.03% |
| 2012-12-31 | $9.88 Million | -- |